| THERAPEUTIC ROUND |
|
| Year : 2010 | Volume
: 55
| Issue : 1 | Page : 47-49 |
|
|
Topical 0.03% atropine vs. 15% aluminum chloride in treating multiple eccrine hidrocystomas: A randomized single blind controlled study
Ehsani Amirhoushang, Mirshams Shashahani Mostafa, Akhyani Maryam, Noormohamadpour Pardis, Noormohamadpour Pedram
Department of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran
Correspondence Address:
Noormohamadpour Pedram
Vahdate eslami Sq, Vahdate-Eslami Ave. Razi Hospital, 11996, Tehran
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.60352
|
|
|
Background: Multiple eccrine hidrocystomas pose a significant treatment challenge due to their facial location and tendency to scar after traditional surgical and other destructive modalities. Aims: To compare two frequently used non-destructive therapeutic modalities. Materials and Methods: Thirty patients with multiple eccrine hidrocystomas were enrolled in the study. They used topical 0.03% Atropine cream and 15% AlCl 3 solution on left and right sides of their face randomly for 4 weeks. All the patients were visited before commencing the therapy as well as two and four weeks later by a dermatologist, blinded to the drugs and the number of lesions. Results: Twenty nine patients (25 females, four males) completed the study. The mean reduction in the number of lesions was significantly higher with Atropine cream in comparison with AlCl 3 solution, 10.2±7.4 vs. 6.2±5.3 ( P < 0.05). There were no recurrences after three months follow-up in both groups. Conclusion: It seems that both Atropine and AlCl 3 are useful therapies in eccrine hidrocytomas but the former might be more effective. We think that other randomized clinical trials with larger sample sizes are needed. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
